We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. OK, I agree | Cookies Policy

TASECTAN®

2

The role of mucoprotectants in the management of gastrointestinal disorders.

Eutamene, Beaufrand Harkat C, Theodorou V.

“The new mucoprotectants, such as gelatin tannate and xyloglucan, have the ability to protect the intestinal mucosa and to exert anti-diarrheal effects. In the future the ability of these substances to enhance the intestinal barrier may extend their use in the management of a variety of gastro-intestinal diseases associated with ‘leaky gut’.

Read more

Undissociated gelatine tannate and xyloglucan prevent gut leakiness and mucosal inflammation induced by LPS: insights in the mechanism of action.

H. Eutamene. P1449.

UEG journal. October 2016. Vol 4. Suppl. 1 Pag A651Introduction:Gelatine tannate (GT) and xylogucan (XG) are commercially available in several countries for the oral treatment of diarrhea in children and adults. However, the mechanism of action remains poorly understood.Aims & Methods...

Read more

Let's meet in..

2020, Sep 14

euroPLX 73 Vienna

Read more

2020, Oct 13

CPhI 2020

Read more

2020, Nov 18

EWMA 2020 VIRTUAL

Read more

2020, Nov 23

euroPLX 74 Athens

Read more